Kevin Hassett, Director of the U.S. National Economic Council, stated there is no reason to be concerned about China cutting off pharmaceutical supplies despite recent tariffs imposed on Chinese goods. He noted the availability of other pharmaceutical sources and recognized the need for more domestic production facilities.

On Thursday, Kevin Hassett, Director of the U.S. National Economic Council, addressed concerns regarding potential retaliation from China in response to recently imposed tariffs on Chinese goods. During an interview on Fox News’ “The Story with Martha MacCallum,” he dismissed fears that China would halt pharmaceutical supplies to the United States due to a 34% tariff announced by President Donald Trump.

Hassett emphasized that there are numerous alternative sources for pharmaceuticals outside of China, stating, “There are lots of other places to get pharmaceuticals. The problem is there aren’t a lot of pharmaceutical plants here in the U.S. and that’s why we have this policy to fix that.” He expressed confidence that there was no need for public concern about interruptions in pharmaceutical supplies from China.

In summary, Kevin Hassett reassured the public regarding the stability of pharmaceutical supplies amidst tariff tensions with China. He highlighted the existence of alternative pharmaceutical sources while acknowledging the need for increased domestic production facilities. His statements aim to alleviate concerns regarding potential supply chain disruptions due to international trade policies.

Original Source: www.tradingview.com

Related posts:

Hassett Dismisses Concerns Over China Cutting Pharmaceutical Supplies Impact of Tariffs on China: Greater Economic Consequences for the U.S. Major U.S. Toymaker Accelerates Shift from China Amid Trade War Impact of Trump’s Tariff Plan: New Taxes on Chinese Packages Starting May 2023